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Background: Microsatellites are nucleotide sequences of tandem repeats occurring throughout the genome, which
have been widely used in genetic linkage analysis, studies of loss of heterozygosity, determination of lineage and
clonality, and the measurement of genome instability or the emergence of drug resistance reflective of mismatch
repair deficiency. Such analyses may involve the parallel evaluation of many microsatellite loci, which are often
limited by sample DNA, are labor intensive, and require large data processing.
Results: To overcome these challenges, we developed a cost-effective high-throughput approach of microsatellite
analysis, in which the amplifications of microsatellites are performed in miniaturized, multiplexed polymerase chain
reaction (PCR) adaptable to 96 or 384 well plates, and accurate automated allele identification has been optimized
with a collective reference dataset of 5,508 alleles using the GeneMapper software.
Conclusions: In this investigation, we have documented our experience with the optimization of multiplex PCR
conditions and automated allele identification, and have generated a unique body of data that provide a starting
point for a cost-effective, high-throughput process of microsatellite analysis using the studied markers.
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Microsatellites are nucleotide sequences of tandem re-
peat units ranging from 1 to 6 nucleotides that occur
throughout the genome. Their polymorphisms, primarily
exhibited as variations in length from the expansion or
contraction of repeat units, reflect the tendency of DNA
polymerase to slip during replication of repeat tracts. Al-
though polymorphic through evolution, microsatellites
are generally stably inherited between closely related in-
dividuals [1]. These attributes have led to their wide use
in genetic linkage analysis, studies of loss of heterozy-
gosity (LOH) in cancer, and in the determination of
lineage and clonality [2].* Correspondence: slakhan@gnif.org
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reproduction in any medium, provided the orOn the other hand, microsatellite instability (MSI) in
tumors, first observed in a proportion of sporadic colon
cancers [3,4] and most colon cancers of hereditary
nonpolyposis colorectal cancer (HNPCC) families [5],
may indicate genetic instability as a result of mismatch
repair (MMR) deficiency [6,7]. The MMR system cor-
rects post-replication base-base mismatches and inser-
tion/deletion loops, and has also been implicated in the
cytotoxicity of some DNA-damaging agents [8,9]. Mis-
match repair deficiency has been observed to exhibit a
high mutation rate [10] and confer tolerance to methy-
lating agents [11,12], cisplatin [13,14], and 6-thioguanine
or 6-mercaptopurine [14,15]. Since the findings of MSI
in colon cancer, the measurement of microsatellite in-
stability has been extended to other solid tumors [16]
and hematological malignancies [17-19], as an indication
of the potential contribution of mismatch repairl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[20-22], and drug resistance.
Depending on the type of analysis, microsatellite
markers are selected based on their chromosomal loca-
tions and frequency of heterozygosity. In genetic linkage
analysis, studies of LOH and the determination of
lineage, polymorphic markers are utilized to distinguish
and follow alleles on homologous chromosomes, while
sensitive and specific measurements of microsatellite in-
stability reflective of mismatch repair deficiency in iso-
lated colon cancer samples are better achieved with
quasimonomorphic mononucleotide markers, including
Bat25, Bat26, NR22, and NR24 [23,24].
In some cases, these studies may involve the parallel
evaluation of many microsatellite loci that are often lim-
ited by sample DNA, can be labor-intensive depending
on the number of loci and samples being examined, and
require the processing of numerous data. To address
these limitations, we demonstrate a cost effective, high-
throughput, and reproducible process of microsatellite
analysis from polymerase chain reaction (PCR) amplifi-
cation to automated data processing using model studies
of microsatellite instability and lineage determination.
Performed in miniaturized and multiplexed PCR format,
our assay evaluates 11 microsatellite loci consisting of
the NCI-recommended panel [25,26] of mononucleotide
markers, Bat25 and Bat26, and dinucleotide markers
(D2S123, D5S2346, and D17S250), and 6 additional di-
nucleotide markers (D3S1262, D3S3623, D6S262,
D7S481, D9S171, and D18S61), that altogether samples
9 chromosomes. We have designed the assay to also
simultaneously evaluate for LOH of mismatch repair
components commonly associated with HNPCC by in-
cluding polymorphic markers, with the exception of
Bat26, that are in close proximity to MLH1 (D3S3623),
MSH2 (Bat26), MSH6 (D2S123), and PMS2 (D7S481)
gene regions. For other applications, markers may be re-
placed or added to the existing assay format with some
optimization. Following the separation of amplified
products by capillary electrophoresis, accurate auto-
mated allele identification is performed with optimized
peak detection algorithm and sizing method using the
GeneMapper software.
Results
A quality high-throughput process of microsatellite ana-
lysis requires specific high-throughput PCR amplifica-
tion of microsatellite regions and automated specific
peak detection, and precise sizing of amplified frag-
ments. In the following, we present optimized conditions
for the amplification of 11 microsatellite loci in two min-
iaturized, multiplexed PCR reactions. We also present
the optimization of analysis methods and marker param-
eters of the GeneMapper software to detect specificpeaks of amplified products from background signals
and precisely size microsatellite fragments in order to
achieve reproducible automated allele identification.
Performance of multiplex PCR
In silico design and optimization to minimize hairpin
and primer-dimer formation as well as cross-
dimerization among possible primer combinations were
performed prior to in vitro testing. Predicted compatible
primer sets were tested and evaluated for optimal assay
performance of low background signals, high fluores-
cence of specific PCR products that fall within the de-
tectable dynamic range, and signal and size resolution
among amplified products. We found that multiplexing
Bat25, Bat26, D3S3623, D5S346, D6S262, and D7S481
into one PCR reaction (group I) and D2S123, D3S1262,
D9S171, D17S250, and D18S61 into another (group II)
met these criteria. The compatibility of primer sets in
our experimental conditions is overall consistent with in
silico predictions. Figure 1 shows the electropherograms
of group I markers amplified with human T-cell lysates
in a 10 μL PCR reaction. Figure 1A displays the
complete spectrum of an individual’s microsatellite pro-
file for group I markers with internal size standards rep-
resented as red peaks. Bat25 and D3S3623 are labeled
with Fam (blue), Bat26 and D6S262 with Hex (green),
and D5S346 and D7S481 with Ned (black). Similarly la-
beled fragments are distally spaced in size by assay de-
sign to accommodate both population size distribution
and possible microsatellite instability. Background sig-
nals from nonspecific priming in multiplex PCR are kept
to a minimum for each fluorescent tag. However, there
is an overlap in the spectral emission of Hex into Fam,
which is most evident at D6S262. These parameters are
examined in detailed for each dye in Figure 1B (Fam),
1C (Hex), and 1D (Ned). Red peaks in Figure 1B–D
mark the size range for each microsatellite marker. In all
three panels, signals from nonspecific products for each
dye are quite low compared to specific signals of ampli-
fied microsatellites. Bleed through of Hex into Fam is
evident in Figure 1B as background microsatellite frag-
ments labeled with Fam that have similar stutter
patterns and size of Bat26 and D6S262. However, this is
not concerning for the genotyping of either Bat25 or
D3S3623 since the nonspecific signal from Bat26 is ex-
tremely low compared to the specific signal of Bat25,
and the expected fragment size range of D3S36S3 is
approximately 40 nucleotides away from the background
peaks from D6S262, which can be excluded from auto-
mated identification by the adjustment of marker and
analysis method parameters in the GeneMapper software.
Alternatively, using narrower band filters for detecting
Fam or exchanging labels to tag markers that are farther










Figure 1 Electropherograms of group I markers. The x-axis represents DNA fragment size in base pairs, and the y-axis represents fluorescence
units. (A) Complete spectrum of group I markers labeled with specific fluorescent tags. D5S346 and D7S481 labeled with Ned, Bat26 and D6S262
labeled with Hex, and Bat25 and D3S3623 labeled with Fam. Similarly labeled fragments are distally spaced in size by assay design to
accommodate population distribution and possible microsatellite instability. Nonspecific signals are kept at a minimum; however, there is overlap
in spectral emission of Hex into Fam, observed as similar stutter peaks with lower signals at Bat26 and D6S262 that are labeled as Fam. (B) Allele
identification of Fam-labeled fragments, Bat25 and D3S3623. Background peaks from the spectral overlap of Hex into Fam were excluded from
identification due to either low nonspecific signals compared to specific signals as in Bat25 or by filtering out with specified marker and analysis
method parameters as in D3S3623. (C) Allele identification of Hex-labeled fragments, Bat26 and D6S262. (D) Allele identification of Ned-labeled
fragments, D5S346 and D7S481.
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Figure 2 Electropherograms of group II markers. The x-axis represents DNA fragment size in base pairs, and the y-axis represents fluorescence
units. (A) Complete spectrum of group II markers labeled with specific fluorescent tags. D9S171 and D17S250 labeled with Ned, D3S1262 and
D2S123 labeled with Hex, and D18S61 labeled with Fam. Similar to group I, the spectral overlap of Hex into Fam is observed at D3S1262 and
D2S123. (B) Allele identification of Fam-labeled fragment, D18S61. Nonspecific stutters from the spectral overlap of Hex into Fam were excluded
from identification by filtering out with specified marker and analysis method parameters. (C) Allele identification of Hex-labeled fragments,
D3S1262 and D2S123. (D) Allele identification of Ned labeled fragments, D9S171 and D17S250. Nonspecific peaks outside of marker size range
were excluded from identification by filtering out with specified marker and analysis method parameters.
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Table 1 Analysis method parameters





Peak detection algorithm Advanced Advanced
Size calling method Local Southern Local Southern
Minimum peak half width 4 points and 2 points
Allele tab





Optimized parameters for automated specific peak detection, precise sizing,
and accurate allele identification.
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amplified with cell lysates in a 10 μL PCR reaction. The
complete spectrum of group II markers is shown in
Figure 2A, consisting of D18S61 labeled with Fam,
D2S123, and D3S1262 labeled with Hex, and D9S171 and
D17S250 labeled with Ned; the amplified products of indi-
vidual dye are analyzed in Figure 2B (Fam), C (Hex), and
D (Ned). Similar to group I, fragments labeled with the
same fluorescent tags are distally spaced apart, and back-
ground signals from nonspecific priming in multiplex
PCR are minimized within the relevant marker size
ranges. The spectral overlap of Hex into Fam is again ob-
served in Figure 2B as microsatellite fragments with the
same stutter patterns and size as D3S1262 and D2S123.
Since these background peaks are present outside the size
range of D18S61, they will not interfere with the genotyp-
ing of D18S61. The nonspecific peak outside of the lower
limit of D9S171 size range in Figure 2D can also be ex-
cluded from identification with specified marker and ana-
lysis parameters. Overall, PCR conditions for groups I and
II markers produce data with clear resolution of specific
signals and sizes of similarly labeled amplified fragments,
which are suitable for high-throughput microsatellite
analysis.
Specific peak detection and precise sizing
Automated data processing was performed with the
GeneMapper software. A reference dataset of 5508 al-
leles from 27 subjects and 1 cancer cell line (Additional
file 1) was used to optimize parameters for specific peak
detection, precise fragment sizing, and accurate allele
identification of amplified microsatellites, which mi-
nimize the recognition of nonspecific artifacts of PCR
amplifications and dye bleed through. Several peak de-
tection algorithms and sizing methods were tested. Su-
perior genotyping quality was observed using the
advanced peak detection algorithm in combination with
the Local Southern sizing method (parameters listed in
Table 1), which determines the best-fit line fragment size
for an unknown fragment from the four nearest sizing
standards based on the reciprocal relationship between
fragment length and mobility ([27] Applied Biosystems,
Part Number 4366831 Rev. A 2005). We also tested dif-
ferent sizing methods, including the third-order least
squares and Global Southern methods, and did not ob-
serve comparable precision as the Local Southern
method. This is consistent with what Ghosh and col-
leagues had observed with fragment sizing [28]. We fur-
ther improved specific peak detection by increasing the
minimum peak half width to 4 points for group I
markers to minimize the recognition of nonspecific
spikes observed in some samples.
Along with peak detection and fragment sizing, pa-
rameters were also optimized for accurate allele callingof amplified microsatellites with unique nucleotide re-
peats. Specific allele identification was promoted by spe-
cifying the size range for each marker (Table 2), using
previously determined values of a population sampling
from the GDB human genome database that have been
adjusted for primer locations and product size in our
assay conditions (Table 3), and also those determined
from 27 additional subjects and 1 cell line in our studies
(Additional file 1). Nonspecific peaks outside the defined
size range for each marker that may interfere with allele
identification of similarly labeled marker, including bleed
through of Hex into Fam, were additionally filtered out
by specified range filters in the analysis method parame-
ters (Table 1). Allele identification of quasimonomorphic
microsatellites with mononucleotide repeats, including
Bat25 and Bat26, was optimized to recognize the highest
peak among stutter peaks as allele 1, and peaks that have
heights >95% of the maximum peak height or height of
allele 1 by setting the mono cut-off value at 0.95 as add-
itional alleles (Table 1). This setting reproducibly identi-
fied at most two alleles for Bat25 and Bat26 per PCR
amplification of a sample without microsatellite instabil-
ity in our dataset.
The reference dataset was also utilized to define bins
for each marker, which are rounded off to specified inte-
ger values that represent different categories of fragment
sizes of amplified products for a particular microsatellite,
to enable automatic allele identification of detected
peaks that fall within the bin settings. The maximum
offset of each bin was set at +/−0.5 base pair to allow up
to one nucleotide range of experimental variations for each
fragment size. Day-to-day inter-experimental and across
time variations related to reagent preparations, PCR am-
plifications, and electrophoretic mobility differences be-
tween experiments resulting in large bin ranges ≥ 1 bp
have been observed by others [28]. Some of these varia-
tions can be adjusted by applying a correction factor based
Table 2 Marker parameters
Multiplex PCR reaction Markers Minimal size Maximum size Marker repeat
1 BAT25 115 145 1
1 BAT26 105 135 1
1 D3S3623 200 230 2
1 D5S346 70 115 2
1 D6S262 160 190 2
1 D7S481 175 205 2
2 D2S123 200 240 2
2 D3S1262 120 150 2
2 D9S171 100 130 2
2 D17S250 175 210 2
2 D18S61 145 180 2
Defined size ranges of markers, which include the GDB human genome database population distribution and additional allele sizes observed in our studies for
optimal automatic allele identification.
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on every run [28], which have been shown to reduce bin
ranges (to ≤ 0.8 bp) and increase interbin distances that
would improve identification of alleles differing in size by
1 bp. We did not perform this correction prior to binning
our initial data set to examine the total variation of our
experiments, and our initial dataset also did not require
1 bp resolution.
Quality of high-throughput microsatellite analysis
We next assessed the performance of the entire high-
throughput process from PCR amplification to auto-
mated data analyses for potential sources of variations
and process accuracy and reproducibility over the course
of 5 months. Subsets of the reference dataset including
studies of microsatellite instability among peripheral T
cell clones from different subjects and lineage determin-
ation of an unknown family, which have beenTable 3 Microsatellite markers size ranges and primer design
PCR
reaction
Marker Range of PCR product
size (bases)
Dye Primer sequenc
1 BAT25 130 Fam FamTCGCCTCCA
1 BAT26 120 Hex HexTGACTACTTT
1 D3S3623 207–223 Fam FamCCATGTTGG
1 D6S262 167–183 Hex HexATTCTTACTG
1 D7S481 181–199 Ned NedTTCTCATTCT
2 D2S123 203–233 Hex gtgtcttAACAGGA
2 D3S1262 132–146 Hex HexCAGTTGTGA
2 D9S171 102–122 Ned NedGTGAACCTC
2 D17S250 188–203 Ned gtgtcttGTAAGCA
2 D18S61 150–176 Fam FamATTTCTAAG
Summary of microsatellite markers, population size ranges for amplified products w
in multiplex PCR amplifications.automatically analyzed with optimized parameters and
bin settings, were utilized in these assessments since the
observed outcome from those studies provided the ap-
propriate controls for comparison.
In those studies, PCR amplifications were performed
in 10 μL reactions with either purified DNA or cell ly-
sates prepared from peripheral T cell clones isolated
from human subjects, which expressed varying growth
rates and were cultured at different times. The inclusion
of different conditions captured the potential variation
associated with sample preparation, including the contri-
bution of background matrix from tissue culture and
DNA isolation. Along with every analysis of unknown
samples, we included the amplification of a known con-
trol sample to distinguish process reproducibility from
sample integrity as the source of variation. Not included
in our comparisons were PCR amplifications of samples
that resulted in no signals or very low signals that doand concentrations in multiplex PCR reactions











ith specific primer sets, and primer sequences, labels, and concentrations used
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trols were performing. These may be the result of inter-
ferences from sample matrix and/or low DNA content
since the use of higher sample volumes resulted in the
successful amplifications of some samples.
The reproducibility of each day’s processing as well as
over the course of 5 months was assessed by examining
the performance of the control samples. Additional files
2 and 3 provide the sizing values for identified alleles of
group I and II markers, which have been amplified with
cell lysates in 23 and 18 different runs, respectively,
and analyzed with optimized parameters using the
GeneMapper software. The sizing values of alleles for
control samples, which reflect processing from PCR am-
plifications of microsatellite regions, fragment separation
by capillary electrophoresis, and specific peak detection
to sizing of fragments were very reproducible over the
course of 5 months showing cumulative %CV ranging
from 0.05% to 0.12% among identified alleles. In
addition, automatic allele identification with indicated
bins was accurate in 360 out 364 alleles analyzed for
markers with dinucleotide repeat units. Although peak
detection and sizing may be accurate, problems with
automatic allele calling of markers with dinucleotide re-
peats occur in cases where signals from nonspecific
products generated during PCR amplifications have
surpassed pre-set threshold values. This was observed
on two occasions for D5S346 as highlighted in blue
(Additional file 2).
We observed the most ambiguity with allele calling of
mononucleotide markers, Bat25 and Bat26 (also shown
in Additional file 4). The algorithm for automatic allele
identification of markers with mononucleotide repeats
was optimized to reproducibly call peaks as alleles by
recognizing the tallest peak as allele 1 and peaks that
meet the preset cut-off value of 95% of the maximum
peak height or allele 1 among stutter peaks as additional
alleles. By this algorithm, Bat25 alleles were identified as
homozygous for 127 bp in 18 of 23 runs of a pooled
control sample and as heterozygous for 127 and 128 nu-
cleotides in 5 runs. Bat26 was identified as 122 bp in all
23 runs. The variations in allele calling of mononucleo-
tide markers reflect the variability in biochemistry of
amplifying regions of mononucleotide repeats due to
DNA polymerase slippage, and relative consistency ap-
pears to depend on pre-set criteria of tolerance for varia-
tions. When these markers were analyzed manually, the
variability is similar or may be subject to more inter-
observer variation in the estimation of differences in
peak heights when compared to automated allele identi-
fication. As these variations likely reflect the tendency of
slippage of DNA polymerase during the amplification of
mononucleotide repeats rather than process variability,
we accepted a deviation of +1 nucleotide as normal forthese markers. This tolerance does not negate the use-
fulness of these markers and/or our methodology. Other
groups considered variations of ≥3 bp for Bat25 and ≥4
bp for Bat26 as true polymorphisms or somatic alter-
ations of these markers [23].
Process accuracy and reproducibility were further ex-
amined in an analysis of 4,440 identified alleles of groups
I and II markers from the amplifications of 240 and 156
T cell clones from 13 and 10 subjects, respectively, in a
microsatellite instability study. This dataset is unique in
that different clones with unique T cell receptor for anti-
gen recognition from the same subjects exhibited identi-
cal patterns of microsatellite profiles or microsatellite
stability, providing the appropriate internal controls for
measuring process deviations. Additional files 4 and 5
provide summaries of identified alleles for groups I and
II markers, respectively, organized in chronological order
by dates of processing, subjects and respective number
of clones analyzed, and the percent deviation from
expected values. Percent deviation from expected values
connotes the percent of alleles that were miscalled, indi-
cated by asterisk. All discordant samples were manually
analyzed to confirm that deviations were unrelated to
microsatellite instability. Misidentifications can represent
failure in any part of the process from sample prepar-
ation, PCR amplification, fragment separation, peak de-
tection, fragment sizing to automated allele calling. The
analysis of 1,920 alleles of dinucleotide markers in group
I (Additional file 4) showed percent deviations from
expected values ranging from 0.0% to 4.69% for day to
day processing and of 0.63% for all days. When discord-
ant samples were analyzed manually, most deviations
from expected allele calls were related to the presence of
higher nonspecific signals or unequal amplifications of
alleles. On the day showing the highest percent devi-
ation, three independent amplifications of control sam-
ples were performed optimally, indicating that the
deviations were likely related to sample integrity. There
was no trend of higher deviations among any of the
markers. As previously mentioned, mononucleotide
markers Bat25 and Bat26 are more difficult to call
whether performed manually or automatically even
though their fragment sizing is very precise (Additional
file 2). We accepted a deviation of +1 nucleotide as nor-
mal and did not calculate a percent deviation for these
markers since all alleles were automatically called within
this range.
The analysis of 1,560 alleles for group II dinucleotide
markers (Additional file 5) showed percent deviations
from expected values ranging from 0.0% to 3.57% for
day to day processing and of 0.77% for all days. Most of
discordant samples showed deviations related to the
presence of higher nonspecific signals and unequal am-
plifications of alleles as observed with group I markers.
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control sample performed optimally, suggesting that
sample integrity is the cause of poor PCR amplifications.
There was also no apparent trend of higher deviations
among any of the markers in group II.
Thus far, we have demonstrated the accuracy and re-
producibility of our high throughput process with con-
trol samples and clones from the same subjects in which
deviations from expected patterns of microsatellites were
analyzed. The accuracy of our methods was also exam-
ined in a lineage determination study of a family of four
members unknown to us. Figure 3 shows the microsatel-
lite profiles of group I markers in four panels that we
have determined as child 1, parent 1, parent 2, and child
2 based on the patterns of segregation of microsatellite
alleles. Alleles inherited from each parent have been ap-
propriately color coded in each child’s microsatellite pro-
files. As previously discussed with the exception of the
ambiguity in identification of Bat25 and Bat26, all alleles
of dinucleotide markers were accurately automatically
identified in Child 1 and Child 2 and can be traced back
to Parent 1 and Parent 2. Furthermore, the microsatellite
profiles of Child 1 and Child 2 were identical, suggesting
that the children are monozygotic twins. The parents
later confirmed these determinations.
Discussion
We have developed a reproducible high-throughput
process of microsatellite analysis in which the amplifica-
tions of microsatellite regions are performed in minia-
turized, multiplexed PCR format; automated allele
identification has been optimized to overcome many
challenges encountered in genetic studies of linkage ana-
lysis, LOH, lineage determination, or microsatellite in-
stability. Our microsatellite assay minimizes sample
requirement using approximately 2–4 ng of DNA in
PCR amplifications of 11 microsatellite loci in two 10 μL
reactions that can be adapted to a 96- or 384-well high-
throughput assay format. Our optimized conditions pro-
duced clear resolution of specific signals and sizes of
amplified microsatellites, allowing for reproducible peak
detection and fragment sizing. The current assay is
amenable to the incorporation of more markers to in-
crease throughput without compromising size resolution
of additional amplified products.
Using the Advanced Peak Detection Algorithm with
specific optimized parameters in combination with the
Local Southern sizing method, our control samples were
precisely sized with %CV ranging from 0.05% to 0.12%
for all markers in groups I and II in 23 and 18 independ-
ent runs, respectively, over the course of 5 months.
These values included the variation from sample prepar-
ation, PCR amplification, fragment separation, peak de-
tection to fragment sizing. For dinucleotide markers,these data also indicate that the addition of the
GTGTCTT tail to our primer sets in conjunction with
optimized extension time have successfully promoted
consistent amplifications of fragment size using a basic
PCR protocol. The observed precision demonstrates the
reproducibility of this process over time.
From a collective reference dataset of 5,508 alleles
from 27 subjects and 1 cell line, we have defined bins or
categories representing different fragment sizes for each
marker to enable automatic allele identification in future
studies with these markers. This dataset is unique in that
sufficient replicates of the same allele have been ampli-
fied using samples from different T cell isolates that have
been cultured and lysed at different times, thus testing a
wide spectrum of variation during sample preparation.
Allowing a bin offset of +/−0.5 base pairs, the perform-
ance of the entire process showed percents deviation
from expected values of 0.63% and 0.77% in 1,920 and
1,560 alleles analyzed for groups I and II dinucleotide
markers, respectively. Most misidentifications were of
nonspecific signals above our preset threshold values or
from the unequal amplifications of alleles, which were
related to poor sample quality rather than process qual-
ity since control samples were performed optimally on
the same runs. We actually expected higher deviations
since all samples from this dataset were amplified with
crude lysates of T cells. In the analysis of control sam-
ples, similarly amplified with crude lysates, we had
leaned towards a higher estimation of the percent devi-
ation by counting both alleles as being miscalled for
marker D5S346 when background signals were also
identified as alleles. Automated allele identification of
quasimonomorphic mononucleotide markers, Bat25 and
Bat26, was highly reproducible using the algorithm of
>95% of maximum height as the cut-off value for identi-
fication of additional alleles and an allowable +1 nucleo-
tide deviation due to the variable biochemistry of
amplifying these markers. These data support the repro-
ducibility and accuracy of this high-throughput process.
We hope that others will benefit from reading about our
experiences and further improve their process. In our
dataset, we have shown two extreme examples: (1) the
analyses of microsatellite stability/reproducibility in the
evaluation of a pooled control sample and clones derived
from individual subjects, and (2) the contrary analyses of
microsatellite instability or divergence of microsatellites
through evolution (accelerated in tumors with mismatch
repair deficiency) when we examined lineage relationship
in the family with monozygotic twins. We expect that
these extreme analyses would reflect the feasibility of our
process in the analyses of tumor cells that exhibit func-
tional deficiency of mismatch repair and other types of
samples, especially since we have also included the five
NCI-proposed markers for the evaluation of MSI.
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Figure 3 Microsatellite profiles of group I markers of family members in lineage determination. The x-axis represents the DNA fragment
size in base pairs, and the y-axis represents the fluorescence units. Relationships among family members were predicted based on the patterns of
inheritance of microsatellite alleles. Child 1 and 2 are monozygotic twins. (A) Microsatellite profile of child 1. Automated identification accurately
called inherited microsatellite alleles of dinucleotide markers, which can be traced back to the microsatellite profiles of parent 1 and parent 2. (B)
Microsatellite profile of parent 1. Alleles have been automatically called with optimized methods. (C) Microsatellite profile of parent 2. Alleles have
been automatically called with optimized methods. (D) Microsatellite profile of child 2. Automated identification accurately called inherited
microsatellite alleles of dinucleotide markers, which can be traced back to the microsatellite profiles of parent 1 and parent 2.
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In this investigation, we have documented our experi-
ence with the optimization of multiplex PCR conditions
and automated allele identification, and have generated a
unique body of data that provide a starting point for a
cost-effective, high-throughput process of microsatellite
analysis using the studied markers. For specific applica-
tions, markers may be exchanged or added with some
optimization to the existing assay format and analysis
methods. For microsatellite instability studies to test the
functional deficiency of mismatch repair, the placement
of polymorphic markers in proximity to mismatch repair
components in this assay may provide additional infor-
mation on LOH.
Methods
Study population and sample collection
T-cells were isolated from healthy controls and a subset
of study participants with inflammatory bowel disease
(n = 12 with Crohn’s disease and n = 7 with ulcerative
colitis) and B cell acute lymphoblastic leukemia (n = 4)
previously recruited from the pediatric and adult gastro-
enterology clinics and pediatric oncology units at Fletcher
Allen Health Care, University of Vermont, and other par-
ticipating Pediatric Oncology Groups/Children’s Oncology
Group institutions [29,30]. Informed consent was ob-
tained from all subjects following procedures approved by
the Committee on Human Research at the University of
Vermont and participating institutions of the cooperative
Pediatric Oncology Group/Children’s Oncology Groups.
Microsatellite assay
The amplifications of 11 microsatellite loci are
performed in two multiplex PCR reactions, consisting of
6 and 5 sets of forward and reverse primers that are ei-
ther labeled with fluorescent tags Hex, Fam or Ned, or
tailed with GTGTCTT nucleotides. Previous research
demonstrated that Taq polymerase can catalyze non-
templated 30 terminal nucleotide addition, primarily ad-
enosine, to amplified DNA fragments. This activity
depends on adjacent DNA sequence context [31-33],
with preferential adenylation following 30-cytidine or
thymidine, resulting in genotyping errors due to varia-
tions in the fractions of adenylated products. Such varia-
tions were improved by performing PCR reactions under
conditions that either favored the production of the true
allele (two-step PCR protocols) or conditions that pro-
duced primarily the adenylated products (three-step
PRC protocols with longer extension times up to 90
min; true allele plus A) for consistent genotyping.
Brownstein further showed that adding specific generic
tails of 6–7 nucleotides to the 50 end of reverse primers
more consistently promoted the adenylation of amplified
DNA products [34]. In our experiments, we have addeda GTGTCTT tail, previously tested by Brownstein, to
the 50 ends of all unlabeled primers and performed PCR
reactions under favorable conditions to promote the
adenylation of the majority of PCR products.
To accommodate variations in microsatellite size
among individuals (range listed in Table 3) and possible
instability, the analyses of multiple loci within the same
PCR reaction are made possible by designing primers,
when labeled with similar fluorescent dyes to prime
products that are at least 40 nucleotides apart in size. Fi-
nally, sample requirement is minimized by the
miniaturization of PCR reactions in 10 μL volume.
DNA samples
DNA templates from both purified DNA as well as
crude cell lysates have been utilized in PCR reactions.
Adequate fluorescence units have been achieved with
amplifications of as low as 0.75 ng of purified DNA and
0.5 μL of lysates of 10,000 T cell pellets. Cell lysates are
prepared by adding 10 μL of lysis reagent containing
80% Qiagen EB buffer (10 mM Tris–HCl pH 8.5;
Qiagen, Inc., Valencia, USA), 0.5% Tween 20, 0.5%
NP40, and 0.1 mg/mL of proteinase K to cell pellets,
followed by incubation at 56°C for 1 h and heat inactiva-
tion at 96°C for 10 min.
PCR conditions
PCR reactions are performed with 10 mM Tris–HCl pH
8.3, 50 mM KCl, 1.5 mM MgCl2, 0.25U or 0.025 U/μL
of platinum (Invitrogen Corporation, Grand Island,
USA) or HotStart-It Taq polymerase (USB Corporation,
Cleveland, USA), primers at concentrations listed in
Table 3, and DNA templates. Reaction mixtures are
heated to 94°C for 2 min for enzyme activation and then
for 35 cycles (94°C for 30 s, 55°C for 30 s, and 72°C for
40 s) with a final extension at 72°C for 10 min.
Microsatellite detection and analysis
Amplified products from PCR reactions 1 and 2 are di-
luted with water. A volume of 1 μL of diluted products
are mixed with 10 μL of formamide and 0.4 μL of
GeneScan 500 Rox size standards (Invitrogen Corpor-
ation), ranging from 35–500 nucleotides, and heat dena-
tured at 95°C for 5 min. PCR products and internal
standard mixtures are then electrophoresed using the
ABI 3100 Avant Genetic Analyzer (Invitrogen Corpor-
ation). Subsequently, automated allele identification is
performed with the GeneMapper software, in which
markers and method parameters (Tables 1 and 2, re-
spectively) have been empirically optimized for specific
peak detection and precise sizing of amplified products,
using the Advanced Peak Detection Algorithm and Local
Southern sizing method, respectively.
Nguyen et al. Human Genomics 2013, 7:6 Page 11 of 12
http://www.humgenomics.com/content/7/1/6Additional files
Additional file 1: Summary of all samples and clones that have
been amplified with optimized PCR conditions using groups I and II
microsatellite markers. Raw data from these samples have been used
to optimize marker and method parameters to achieve specific peak
detection, precise fragment sizing, and accurate automated allele
identification. Sizing values and allele calls for 5,508 alleles have been
automatically analyzed with optimized parameters and bin settings, using
the Advanced Peak Detection Algorithm in combination with the Local
Southern sizing method. Samples or clones with asterisk represent those
that have been miscalled by automated allele identification.
Additional file 2: Process reproducibility with group I markers.
Summary of sizing values of identified alleles for each marker from the
amplification of control samples in 23 independent runs over the course
of 5 months. Averages, standard deviations, and %CVs have been
calculated for each allele. Process variation includes sample preparation,
PCR amplification, fragment separation, peak detection, and fragment
sizing.
Additional file 3: Process reproducibility with group II markers.
Summary of sizing values of identified alleles for each marker from the
amplification of control samples in 18 independent runs over the course
of 1 month. Averages, standard deviations, and %CVs have been
calculated for each allele. Process variation include sample preparation,
PCR amplification, fragment separation, peak detection, and fragment
sizing.
Additional file 4: Process accuracy with group I markers. Summary
of results from automated allele identification of 1,920 dinucleotide
markers and 960 mononucleotide markers from 239 T cell clones from
different subjects organized by dates of processing.
Additional file 5: Process accuracy with group II markers. Summary
of results from automated allele identification of 1,560 dinucleotide
markers from 156 T cell clones from different subjects organized by dates
of processing. Percent deviation from expected values connotes the
percent of alleles that have been miscalled, indicated by an asterisk.
Misidentification can represent failure in any part of the process from
sample preparation, PCR amplification, fragment separation, peak
detection, fragment sizing, to automated allele calling. We manually
analyzed all discordant samples and found failures to be related to either
the interferences of nonspecific signals above threshold values or from
the unequal amplification of alleles. These failures were likely related to
poor sample quality since control samples were performed optimally in
the same runs.
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